Logo image of EYPT

EYEPOINT PHARMACEUTICALS INC (EYPT) Stock Analyst Ratings

NASDAQ:EYPT - Nasdaq - US30233G2093 - Common Stock - Currency: USD

7.8  +0.18 (+2.36%)

After market: 7.77 -0.03 (-0.38%)

Buy % Consensus

84

ChartMill assigns a Buy % Consensus number of 84% to EYPT. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 33.66. This target is 331.54% above the current price.
EYPT was analyzed by 18 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about EYPT.
In the previous month the buy percentage consensus was at a similar level.
EYPT was analyzed by 18 analysts, which is quite many. So the average rating should be quite meaningful.
EYPT Historical Analyst RatingsEYPT Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -97 -88 -79 -70 -61 -52 -43 -34 -25 -16 -7 5 10 15

Price Target & Forecast

Price Low Median Mean High 7.8018.1829.5833.6671.40 - 133.08% 279.23% 331.54% 815.38%
EYPT Current Analyst RatingEYPT Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8 10
Up and Down Grades
Date Firm Action Rating
2025-01-07 Citigroup Initiate Buy
2024-12-05 HC Wainwright & Co. Reiterate Buy -> Buy
2024-11-11 Baird Maintains Outperform -> Outperform
2024-11-11 HC Wainwright & Co. Maintains Buy -> Buy
2024-11-08 Chardan Capital Maintains Buy -> Buy
2024-10-29 Chardan Capital Maintains Buy -> Buy
2024-10-25 HC Wainwright & Co. Reiterate Buy -> Buy
2024-10-16 ScotiaBank Initiate Sector Outperform
2024-08-28 Jefferies Initiate Buy
2024-08-13 JP Morgan Maintains Overweight -> Overweight
2024-06-28 Chardan Capital Maintains Buy -> Buy
2024-06-27 HC Wainwright & Co. Reiterate Buy -> Buy
2024-06-20 Cantor Fitzgerald Reiterate Overweight
2024-06-04 JP Morgan Maintains Overweight -> Overweight
2024-05-13 HC Wainwright & Co. Maintains Buy -> Buy
2024-05-08 Baird Maintains Outperform -> Outperform
2024-05-07 Chardan Capital Maintains Buy -> Buy
2024-05-07 Mizuho Maintains Buy -> Buy
2024-03-08 HC Wainwright & Co. Maintains Buy -> Buy
2024-02-16 Mizuho Maintains Buy -> Buy
2024-01-22 JP Morgan Initiate Overweight
2024-01-16 HC Wainwright & Co. Maintains Buy -> Buy
2023-12-11 Capital One Initiate Overweight
2023-12-07 Mizuho Maintains Buy -> Buy
2023-12-05 HC Wainwright & Co. Maintains Buy -> Buy
2023-11-02 Mizuho Initiate Buy
2023-11-02 HC Wainwright & Co. Maintains Buy -> Buy
2023-09-14 Cantor Fitzgerald Reiterate Overweight -> Overweight
2023-09-12 HC Wainwright & Co. Reiterate Buy -> Buy
2023-08-31 Cantor Fitzgerald Reiterate Overweight -> Overweight